AIDS News and Research

RSS

Study launched to test a vaginal film that slowly dissolves over the course of 30 days

A vaginal film designed to slowly dissolve over the course of 30 days is being put to the test for the first time in a study launched this week that aims to determine its feasibility and acceptability as a potential HIV prevention method for women.

2 Nov 2023

NIH awards $2.1 million to UCLA to end the HIV epidemic

The National Institutes of Health (NIH) has granted $2.1 million to UCLA's Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

2 Nov 2023

Added calcium and phosphate in fluoride varnishes no silver bullet for fighting kids' tooth decay, study finds

The study explores the effectiveness of sodium fluoride varnishes with added calcium and phosphate versus conventional varnishes in reducing harmful bacteria in preschool children's mouths. Results indicate no significant difference between the two types of varnishes in controlling bacterial growth, calling for more research on effective ways to combat early childhood caries.

1 Nov 2023

Does the percentage of slow-wave sleep decline with aging, and are intra-individual declines associated with dementia risk?

Researchers investigated whether slow-wave sleep (SWS) proportions reduced as individuals aged and whether intra-individual decreases were linked to dementia risk.

1 Nov 2023

Rise in skin cancer cases underscores importance of early detection using machine learning

Image-processing techniques in machine learning (ML) for skin cancer detection using clinical images.

30 Oct 2023

Current jargon on antibiotic resistance fails to stick or scare, study finds

Researchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like "AMR" and "antimicrobial resistance" are poorly remembered and do not evoke sufficient risk perception, highlighting the need for improved public health messaging.

29 Oct 2023

Cuproptosis subtypes and immune infiltration provide insights into prognosis of hepatocellular carcinoma

Announcing a new publication for Acta Materia Medica journal. The role of cuproptosis, a newly discovered form of programmed cell death, remains poorly understood in hepatocellular carcinoma (HCC).

27 Oct 2023

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

The therapeutic potential of resveratrol, a red grape polyphenol.

25 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Let’s have an honest conversation about what to expect as you age

How many of us have wanted a reliable, evidence-based guide to aging that explains how our bodies and minds change as we grow older and how to adapt to those differences?

20 Oct 2023

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

18 Oct 2023

One in five Norwegians suffering from inadequate tinnitus treatment

Researchers have concluded that many people are suffering unnecessarily and that treatment provision offered to patients is failing at many levels.

18 Oct 2023

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

16 Oct 2023

New study shows higher lung cancer incidence in women than in men

Reversing historical patterns, new findings led by researchers at the American Cancer Society (ACS) show higher lung cancer incidence in women than in men has not only continued in adults younger than 50 years, but now extends to women 50 to 54 years of age in the United States.

13 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

AIDS News and Research

Study launched to test a vaginal film that slowly dissolves over the course of 30 days

NIH awards $2.1 million to UCLA to end the HIV epidemic

Added calcium and phosphate in fluoride varnishes no silver bullet for fighting kids' tooth decay, study finds

Does the percentage of slow-wave sleep decline with aging, and are intra-individual declines associated with dementia risk?

Rise in skin cancer cases underscores importance of early detection using machine learning

Current jargon on antibiotic resistance fails to stick or scare, study finds

Cuproptosis subtypes and immune infiltration provide insights into prognosis of hepatocellular carcinoma

Groundbreaking research advances understanding of how pathogens impact cancer

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Let’s have an honest conversation about what to expect as you age

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

One in five Norwegians suffering from inadequate tinnitus treatment

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

New study shows higher lung cancer incidence in women than in men

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

KFF Health News' 'What the Health?': Health funding in question in a speaker-less Congress

PrEP, a key HIV prevention tool, isn’t reaching Black women

Syphilis rates twice as high among transgender women and Black gay and bisexual men in Chicago

The critical role of model interpretation in diabetes decision support systems

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News